Press Release Archive

10.03.2011

Medimmune'in(Licenses'cancer'immunotherapy'tremelimumab'from'pfizer

10.03.2011

Pfizer Invites Public To View And Listen To Webcast Of November 1 Conference Call With Analysts

09.30.2011

Excellence in Scientific Innovation and Humanitarian Efforts Honored at 2011 Prix Galien Award Ceremony

09.29.2011

Pfizer Reports Top-Line Results Of A Phase 3 Clinical Trial Comparing The Efficacy And Safety Of VFEND® (voriconazole) And ERAXISTM (anidulafungin) Combination Therapy To VFEND Alone In Invasive Aspergillosis

09.28.2011

The National Association Of Boards Of Pharmacy And Pfizer Partner To Educate Patients About The Flood Of Counterfeit Medicines Online

09.28.2011

International Structural Genomics Consortium Announces $48.9 MILLION in Additional Funding to Continue the Search for New Medicines

09.22.2011

Even Famous Faces Have an Advil® Story to Share

09.21.2011

New Phase 3 Safety Data For Bazedoxifene/Conjugated Estrogens, An Investigational Therapy Being Studied For The Treatment Of Menopausal Symptoms, Show Less Than One Percent Incidence Of Endometrial Hyperplasia

09.19.2011

Pfizer Announces Expiration of Subsequent Offering Period and Completion of Tender Offer for Shares of Icagen, Inc.

09.12.2011

Pfizer Extends Subsequent Offering Period of Tender Offer to Acquire Icagen, Inc.

09.12.2011

Pfizer to Present Clinical Data from Oncology Portfolio at the 2011 European Multidisciplinary Cancer Congress

09.09.2011

Lpath Initiates Dosing of iSONEP in First of Two Proof-ofConcept Trials